$111.95
-3.86-3.33%
가까이에: Sep 25, 5:00 PM EST
$111.95
N/A
시간외: 4:00 PM EST
Benzinga
Benzinga
Benzinga
토요일, 9월 26
Kymera Therapeutics Inc
KYMRNASDAQ
Kymera Therapeutics Earnings & Forecasts
Kymera Therapeutics (KYMR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Kymera Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.72 | $-0.86 | $-0.78 | $-0.76 |
| Actual | $-0.62 | $-0.71 | $-0.97 | $-0.90 |
| Surprise | +13.9% | +17.4% | -24.4% | -18.4% |
| Revenue | ||||
| Estimate | $32.6M | $8.8M | $16.2M | $24.5M |
| Actual | $65.0M | $34.4M | $2.9M | $2.8M |
| Surprise | +99.6% | +291.1% | -82.3% | -88.7% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.25 | $-1.26 | $-1.39 | $-1.42 |
| Revenue | ||||
| Consensus | $3.7M | $4.3M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved